Plasma Fibrinogen Gene Β-455G/a Polymorphism and Plasma Fibrinogen Level in Patients with Acute Coronary Syndromes

卢成志,田浩明,李玉光
DOI: https://doi.org/10.3969/j.issn.1671-6272.2003.06.001
2003-01-01
Abstract:Objectives To investigate the relationship between the β fibrinogen gene -455G/A polymorphism and plasma fibrinogen level and to determine the influence of the acute coronary syndromes. Methods Eighty-nine patients with ACS, ninety-seven patients with SAP and OMI, and 63 control subjects. The β fibrinogen gene 455G/A polymorphism was analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) with the restriction enzyme Hae Ⅲ, while plasma fibrinogen levels were obtained from the prothrombin time assay. Results The plasma fibrinogen levels were significantly higher in patients with ACS than that in the controls (P0.01). A allele frequency was higher in patients with ACS than patients with SAP and OMI, and control subjects. Higher plasma fibrinogen levels were shown in the subjects with A -alleles (AA +GA genetype) than the subjects with G-alleles (GG genetype) (P0.05). Conclusion The promoter region of β fibrinogen gene 455G/A polymorphism is associated with the produce and development of ACS, and at the same time impact on the plasma Fg concentration. The A allele frequency in patients with ACS was significantly higher and the A allele gene may be a risk factor for ACS.
What problem does this paper attempt to address?